posteditor

B BOSTON, April 28, 2026 /PRNewswire/ — Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced it will present two… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B NEW YORK, April 28, 2026 /PRNewswire/ – Galaxy Digital Inc. (Nasdaq: GLXY) (the “Company” or “GDI”) today released financial results for the three months ended… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B HANGZHOU, China, April 28, 2026 /PRNewswire/ — Dahua Technology, a world-leading video-centric AIoT solution and service provider, has released its seventh Environmental, Social and Governance… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B     NASDAQ | TSX: ACB Q1 launches reinforce Aurora’s medical‑first strategy, expanding access to high‑quality products across multiple formats Scaled launches across Canada, Europe… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B SAN FRANCISCO, April 28, 2026 /PRNewswire/ — Hep B Free and the Coalition for Global Hepatitis Elimination (CGHE), a program of The Task Force… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B CLEVELAND, April 28, 2026 /PRNewswire/ — Hyster-Yale, Inc. (NYSE: HY) announced today it will release its First Quarter 2026 financial results after the market… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B First quarter net sales of $2.087 billion increased 9.3% on a reported basis, 6.8% on a constant currency1 basis and 2.9% on an organic… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B CLEVELAND, April 28, 2026 /PRNewswire/ — NACCO Industries® (NYSE:NC) will release its 2026 First Quarter financial results after the close of the market on… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B – Proven Leader in Neurology Drug Development, Including for Several Approved Multiple Sclerosis Therapies – – Strong Experience in Advancing Late-Stage Clinical Programs and… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

B Suketu Upadhyay to Depart; Paul Stellato Named Interim CFO WARSAW, Ind., April 28, 2026 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a… Login to continue reading Login Sign up for complimentary access Sign Up Now Close